Vycor Medical (VYCO) Depreciation & Amortization (CF) (2010 - 2026)
Vycor Medical (VYCO) reported Depreciation & Amortization (CF) of $15668.0 for Q1 2026, down 2.74% year-over-year from $16110.0 in Q1 2025, and down 2.95% quarter-over-quarter from $16144.0 in Q4 2025.
Vycor Medical (VYCO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $15668.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $15668.0, down 2.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $62701.0 (down 2.64% YoY), and the FY2025 annual result was $63143.0, down 1.2% from the prior year.
- Depreciation & Amortization (CF) declined to $15668.0 in Q1 2026 per VYCO's latest filing, from $16144.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $16869.0 in Q4 2024 and troughed at $15021.0 in Q2 2025.
- A 5-year average of $15580.9 and a median of $15563.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) surged 39.43% in 2022, then declined 4.3% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $15330.0 in 2022, then slipped by 1.49% to $15102.0 in 2023, then climbed by 11.7% to $16869.0 in 2024, then dropped by 4.3% to $16144.0 in 2025, then retreated by 2.95% to $15668.0 in 2026.
- Business Quant data shows VYCO's Depreciation & Amortization (CF) at $15668.0 in Q1 2026, $16144.0 in Q4 2025, and $15868.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | 15,668.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,668.00 |
| Mar 31, 2026 | 15,668.00 |
| Dec 31, 2025 | 16,144.00 |
| Dec 31, 2025 | 16,144.00 |
| Sep 30, 2025 | 15,868.00 |
| Sep 30, 2025 | 15,868.00 |
| Jun 30, 2025 | 15,021.00 |
| Jun 30, 2025 | 15,021.00 |
| Mar 31, 2025 | 16,110.00 |
| Mar 31, 2025 | 16,110.00 |
| Dec 31, 2024 | 16,869.00 |
| Dec 31, 2024 | 16,869.00 |
| Sep 30, 2024 | 15,740.00 |
| Sep 30, 2024 | 15,740.00 |
| Jun 30, 2024 | 15,681.00 |
| Jun 30, 2024 | 15,681.00 |
| Mar 31, 2024 | 15,620.00 |
| Mar 31, 2024 | 15,620.00 |
| Dec 31, 2023 | 15,102.00 |
| Dec 31, 2023 | 15,102.00 |